As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …

Females are generally more affected by autoimmune diseases, a fact that underlines the
relationship with pregnancy and the safety of anti-rheumatic drugs in pregnancy and …

Psoriasis is a common disease, which has a considerable impact on the healthcare system.
Therefore, appropriate use of therapeutic resources is very important. Management of …

Aims TNF‐α inhibitors are considered relatively safe in pregnancy but experience is still
limited. The aim of this study was to evaluate the risk of major birth defects, spontaneous …

1.1 Bedarfsanalyse/Probleme in der Versorgung der Patienten Die Psoriasis vulgaris stellt
eine häufige und fast immer chronisch verlaufende dermatologische Erkrankung dar. Die …

The safety of biologic agents during pregnancy is still being investigated. Tumor necrosis
factor α (TNF‐α) inhibitors are the only well‐studied biological drugs in pregnancy; they do …

Introduction: An increasing number of female patients with autoimmune diseases are treated
with biologic drugs. Concerns in regard to safety of biologics during pregnancy arise in …

Introduction: Rheumatoid arthritis (RA) can spontaneously improve during pregnancy.
However, a considerable proportion of patients can experience a flare and high disease …

From 2002 to 2016 a total of seven women with severe refractory psoriasis were exposed to
the TNF‐inhibitors infliximab and adalimumab or to the IL12/23 inhibitor ustekinumab during …

Thalidomide, a drug known for its teratogenic side-effects, is used successfully to treat a
variety of clinical conditions including leprosy and multiple myeloma. Intense efforts are …